AuthorsPrice, Patricia M
AffiliationDepartment of Cancer Therapeutics, ICSM Academic, Department of Radiation Oncology, Christie Hospital, Manchester, England.
MetadataShow full item record
AbstractCholangiocarcinoma is a rare tumor. Many cases are localized while metastatic disease within the liver and abdomen do occur. There is as yet no standard therapy for advanced bile duct tumors. Radiotherapy and chemotherapy are not curative modalities in this condition but are being assessed adjuvantly following surgery, and as palliative treatment in an attempt to either extend progression-free and overall survival or to palliate symptoms. Advances may be made by: (i) The combined use of radiation and chemotherapy, (ii) High dose conformal radiotherapy, (iii) Novel chemotherapeutic agents. Patients should be given the opportunity to participate in clinical trials.
CitationCholangiocarcinoma and the role of radiation and chemotherapy., 48 (37):51-2 Hepatogastroenterology
- Arterial chemotherapy and conformal radiation abolish malignant biliary obstruction.
- Authors: Guan YS, Qing He, Ping Li, Fu YC, Zhao SW
- Issue date: 2008 Mar
- Radiotherapy and multimodality management of cholangiocarcinoma.
- Authors: Urego M, Flickinger JC, Carr BI
- Issue date: 1999 Apr 1
- The multidisciplinary management of gastrointestinal cancer. Biliary tract cancers: from pathogenesis to endoscopic treatment.
- Authors: Demols A, Maréchal R, Devière J, Van Laethem JL
- Issue date: 2007
- Diagnosis and management of cholangiocarcinomas: a comprehensive review.
- Authors: Yalcin S
- Issue date: 2004 Jan-Feb
- Consideration of the role of radiotherapy for unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 75 patients.
- Authors: Zeng ZC, Tang ZY, Fan J, Zhou J, Qin LX, Ye SL, Sun HC, Wang BL, Li D, Wang JH, Zeng MS, Guo W, Tan YS
- Issue date: 2006 Mar-Apr